Medicare Enrolled

Dr. Gladys Rodriguez, M.D.

Hematology & Oncology · San Antonio, TX
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Speaking/Promotional
4383 MEDICAL DR, San Antonio, TX 78229
2105935700
In practice since 2006 (19 years)
NPI: 1548284722 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Rodriguez from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rodriguez? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Rodriguez

Dr. Gladys Rodriguez is a hematology & oncology specialist in San Antonio, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Rodriguez performed 9,696 Medicare services across 1,168 unique beneficiaries.

Between the years covered by Open Payments, Dr. Rodriguez received a total of $11,531 from 31 pharmaceutical and/or device companies across 96 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Rodriguez is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 37% volume in TX $11,531 industry payments

Medicare Practice Summary

Medicare Utilization ↗
9,696
Medicare services
Top 37% in TX for hematology & oncology
1,168
Unique beneficiaries
$20
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~510 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Denosumab injection (Prolia/Xgeva) 6,900 $18 $71
Comprehensive metabolic blood panel 489 $10 $32
Complete blood count (CBC) with differential 464 $8 $23
Blood draw (venipuncture) 396 $8 $15
Office visit, established patient (30-39 min) 240 $91 $373
Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 202 $20 $62
Office visit, established patient (20-29 min) 157 $58 $263
Injection, zoledronic acid, 1 mg 145 $6 $69
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less 127 $22 $86
Drug injection, under skin or into muscle 114 $11 $47
Administration of chemotherapy into vein, 1 hour or less 111 $98 $376
Iron binding capacity test 58 $8 $26
Ferritin level test (iron stores) 57 $13 $41
Iron level test 57 $6 $19
Complete blood count (CBC), automated 51 $6 $19
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less 41 $45 $185
Office visit, established patient, complex (40-54 min) 34 $122 $523
Vitamin B-12 level test 22 $14 $45
Carcinoembryonic antigen (cea) protein level 17 $19 $57
New patient office visit, complex (60-74 min) 14 $159 $640
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.7% high complexity
75.0% medium
23.3% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$11,531
Total received (2018-2024)
Avg $1,647/year across 7 years
Top 30% in TX for hematology & oncology
31
Companies
96
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$4,965 (43.1%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$3,112 (27.0%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,909 (16.6%)
Other
Charitable contributions, space rental, and other categories
$1,545 (13.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,113
2023
$2,655
2022
$325
2021
$5,521
2020
$147
2019
$248
2018
$522

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
PFIZER INC.
$4,468
E.R. Squibb & Sons, L.L.C.
$3,617
Novartis Pharmaceuticals Corporation
$1,265
AstraZeneca Pharmaceuticals LP
$338
NOVARTIS PHARMACEUTICALS CORPORATION
$299
Daiichi Sankyo Inc.
$249
Exelixis Inc.
$186
Genentech USA, Inc.
$142
AbbVie, Inc.
$132
Alexion Pharmaceuticals, Inc.
$117
Amgen Inc.
$102
Regeneron Healthcare Solutions, Inc.
$71
Boehringer Ingelheim Pharmaceuticals, Inc.
$69
Lilly USA, LLC
$64
Gilead Sciences, Inc.
$59
Takeda Pharmaceuticals U.S.A., Inc.
$42
Heron Therapeutics, Inc.
$41
Foundation Medicine, Inc.
$34
Medtronic USA, Inc.
$28
Stemline Therapeutics Inc.
$21
Helsinn Therapeutics (U.S.), Inc.
$20
Janssen Biotech, Inc.
$20
ADC Therapeutics America, Inc.
$19
AbbVie Inc.
$19
Bayer Healthcare Pharmaceuticals Inc.
$18
Merck Sharp & Dohme Corporation
$18
Apellis Pharmaceuticals, Inc.
$16
Astellas Pharma US Inc
$16
Bayer HealthCare Pharmaceuticals Inc.
$15
Amneal Pharmaceuticals LLC
$15
Merck Sharp & Dohme LLC
$12
Top 3 companies account for 81.1% of total payments
Associated products mentioned in payments ›
AKYNZEO · AVASTIN · Andexxa · CABOMETYX · CINVANTI · Cabometyx · DARZALEX · ENHERTU · Empaveli · Enhertu · FOUNDATIONONE · GILOTRIF · Herceptin · Humira · INJECTAFER · INLYTA · Itovebi · KEYTRUDA · KISQALI · Kadcyla · Kyprolis · LIBTAYO · LYNPARZA · NINLARO · Neulasta · Nplate · Nubeqa · Orserdu · SYNCHROMED · Stivarga · VENCLEXTA · VERZENIO · Venclexta · Xospata
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (43%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in hematology & oncology and does not inherently indicate bias, but patients may wish to be aware.

Equivalent to $119 per 100 Medicare services performed
Looking for a hematology & oncology specialist in San Antonio?
Compare hematology & oncology specialists in the San Antonio area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncology specialists nearby

Geographic Context

Hematology & oncology specialists within 10 mi
56
Per 100K population
2.7
County median income
$70,571
Nearest hospital
UNIVERSITY HEALTH SYSTEM
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Rodriguez is a mixed practice specialist, with moderate Medicare volume, with speaking/promotional industry engagement, with 19 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Rodriguez experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Rodriguez performed 6,900 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Rodriguez receive payments from pharmaceutical companies?
Yes. Dr. Rodriguez received a total of $11,531 from 31 companies across 96 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rodriguez's costs compare to other hematology & oncology specialists in San Antonio?
Dr. Rodriguez's average Medicare payment per service is $20. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rodriguez) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →